ATRO Medical is addressing an important group of patients with knee osteoarthritis, who had a partial or total meniscectomy (removal of meniscus tissue). This Dutch based innovator, has developed an anatomically shaped meniscus prosthesis. ATRO Medical now aims to further accelerate their development in cooperation with Medace.

Jan Hunik (CEO): ‘Our Trammpolin® meniscus prosthesis can make an important impact on the lives of patients suffering from knee pain after a meniscectomy. Medace helps us to accelerate in a flexible and cost effective way with the pre-clinical tests of our product through the usage of their advanced Research and Development facilities. This allows us to focus on the test results without having to make large capital expenses. We look forward to the intense collaboration and to learning from these qualified professionals.’

ATRO Medical was founded in 2016 as a spin-off from the Radboudumc and DSM Biomedical. With their treatment, the damaged meniscus can be replaced aiming at pain relief and improved normal daily mobility. The innovation potential of this implant has been recognized already by the FDA in the US, qualifying it as a ‘breakthrough device’.